CTC Alternative Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$672K Buy
+560
New +$572K 0.97% 24
2025
Q1
Sell
-1,300
Closed -$1M 111
2024
Q4
$1M Buy
1,300
+674
+108% +$558K 1.21% 15
2024
Q3
$555K Buy
+626
New +$563K 0.69% 22
2013
Q3
Sell
-9,900
Closed -$486K 148
2013
Q2
$486K Buy
+9,900
New +$539K 0.13% 63

Other funds holding LLY

CTC Alternative Strategies's LLY Position: Q2 2026 in Review

CTC Alternative Strategies opened a new position in Eli Lilly (LLY) in Q2 2026: 560 shares worth $672K. The stake represents 0.97% of the portfolio and ranks #24 among its holdings. This is a return to the name: CTC Alternative Strategies previously reported a position in LLY as recently as Q4 2024.

CTC Alternative Strategies first reported a position in LLY in Q2 2013 and has held it in 4 quarters since. The position peaked at $1M in Q4 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CTC Alternative Strategies held 560 shares of Eli Lilly worth $672K as of Q2 2026.
  • Eli Lilly was a new CTC Alternative Strategies position in Q2 2026.
  • Eli Lilly made up 0.97% of CTC Alternative Strategies's portfolio in Q2 2026, its #24 holding.
  • CTC Alternative Strategies first reported a position in Eli Lilly in Q2 2013 and has held it in 4 quarters since.
  • CTC Alternative Strategies's Eli Lilly position peaked at $1M in Q4 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CTC Alternative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.